| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87733d521bb0bd5932c206a3fcf6a275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4b6bed385b12386c8396402a1caf0b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af9a111117d20ecf525c76e26daa40b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6f677855b41682531902de49afbd5fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf85c995ccaf0d27cd9f8bac14b7ce20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4aa9994b991d765ba6f52167f7d8d31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4caa77d6ee705e63ba9d4a406c6e5094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2320c55301e5298f4da8ef365aeda792
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09d195fadc42b53435890ef8d96e7bc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90c3702d69494d24f691303fe630cc94 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4709 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2011-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_708f422ae1c5b43461b6045336b38b21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71889839a444c553d30e3566ae31d7cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bc4fa25c99bce45ead4fb801c993c03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edd1a4c9817efd1e41560eb76f8a3d47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82973bde491a822d535d1e14a45126ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97f4a0bfd240e26f682c077b336be519 |
| publicationDate |
2011-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011124376-A1 |
| titleOfInvention |
New formulations for diagnosis of alzheimer's disease |
| abstract |
The invention relates to the use of at least one quantitative ratio (quotient) of two amyloid beta peptidea (A beta; Aß) which are different from one another in a sample of a bodily fluid of a test subject and/or patient in order to determine the probability (risk) of said test subject and/or patient suffering Alzheimer's disease (Morbus Alzheimer, AD) and/or to determine (diagnose) suffering from an early stage of Alzheimer's disease, wherein the amyloid beta peptides are selected from (a) Aß(1-42), (b) Aß(2-40) and (c) Aß(2-42) and wherein the quantitative ratio of (a) / (b) or vice versa and/or of (a) / (c) or vice versa is formed. The invention also relates to a corresponding method and to a kit for use in this connection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103852579-A |
| priorityDate |
2010-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |